Dr. Reckeweg R30 Atomare Beckeron
Product Images NDC 53346-1330

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dr. Reckeweg R30 Atomare Beckeron (NDC 53346-1330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmazeutische Fabrik Dr. Reckeweg & Co, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Carton Label (Ec13cadd 84f7 49bf Af16 Ffc2f6a8f731)

Image Of Carton Label (Ec13cadd 84f7 49bf Af16 Ffc2f6a8f731)
This appears to be a drug facts label for a homeopathic pain-relief cream named Atomare Beckeron. The label includes a warning against use by people hypersensitive to plants of the Anacardiaceae family, pregnant people or those with bronchial asthma or whooping cough, and children under five years. The label cautions against applying the ointment on the face and to damaged or injured mucous membranes, and advises to avoid contact with eyes. Users are advised to apply the ointment over the affected area two or three times daily or as recommended. It is indicated for temporary relief of muscle and joint pain, sports injuries, and bruising. The drug facts label notes that the cream contains both active and inactive ingredients. The active ingredients include Gamphora, Armica montana, radx, Beladonna, Calendula officinals, Dulcamara, Echinacea, Hemameis virginiana, Hypericum perforatum, Milsfoium, Nox vorica, and Rhus toxicodendron. The inactive ingredients include Cetostearyl alcohol, lavender oil, olive oil, petrolatum, rosemary oil, Scots pine oil, and wool wax alcohol. The drug facts label urges users to wash their hands thoroughly after use, retain the outer carton for full product information, and keep the product out of reach of children. If symptoms persist or worsen, the user is advised to stop use and consult a doctor.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.